| [ Summary ] |
Exit-site infection is a major complication of continued CAPD treatment. Catheter biocompatibility, poor immunity and skin defense dysfunction aggravate exit-site infection in patients with end-stage renal disease. The vast majority of cultured microorganisms are Gram-positivive Cocci. There are different prognosis and the treatments are determined by the kind of microorganism responsible. For example, many patients with MRSA or Pseudomonas infections were not able to recover, even if unroofing was performed. This may be the case even when various catheter care techniques for prevention of these problems has been carried out. However, there is no consensus as to the best management strategy for preventing exit-site infection. Thus, systematic research is necessary to solve this problem. |